Back to search
Hypertension Secondary
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hypertension Secondary trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hypertension Secondary trials you may qualify forBackground: One way to treat liver cancer is to deliver chemotherapy drugs only to the liver (and not to the whole body). Researchers want to see if adding the…
High blood pressure during pregnancy poses significant risks to both the mother and baby. A combination of factors, including advancing maternal age, rising obe…
The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these disea…
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
TX000045-003 is a double-blind, randomized, parallel group, placebo-controlled, proof- of-concept (POC) study, evaluating 2 dose regimens of TX000045 over the c…
Pulmonary hypertension secondary to left heart disease is associated with increased morbidity and mortality, particularly in patients with rheumatic chronic val…
This study will examine and test healthy volunteers and patients with pulmonary hypertension to try to learn more about the disease and find better ways to dete…
PH-HFpEF patients will receive open-label doses of levosimendan and be periodically evaluated for safety in extended use.
The purpose of this study is to determine how often people with sickle cell anemia develop pulmonary hypertension a serious disease in which blood pressure in t…